Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Sarepta Therapeutics, Inc.
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2,577.11 |
2,949.65 |
3,222.46 |
3,108.14 |
3,220.22 |
| Przychód Δ r/r |
0.00% |
14.46% |
9.25% |
-3.55% |
3.61% |
| Przychód (min) |
1,971.23 |
2,342.06 |
3,200.57 |
2,517.91 |
2,608.70 |
| Przychód (max) |
2,824.58 |
3,897.15 |
3,244.35 |
3,662.10 |
3,794.16 |
| EBITDA (średnia) |
-1,070.82 |
-1,225.61 |
-1,338.97 |
-1,291.47 |
-1,338.04 |
| EBIT (średnia) |
-1,214.16 |
-1,389.67 |
-1,518.20 |
-1,464.34 |
-1,517.14 |
| EBIT % |
-47.11% |
-47.11% |
-47.11% |
-47.11% |
-47.11% |
| Zysk netto (średni) |
-185.68 |
770.04 |
983.70 |
847.67 |
905.11 |
| Zysk netto % |
-7.21% |
26.11% |
30.53% |
27.27% |
28.11% |
| EPS (średnia) |
-1.72 |
6.88 |
9.02 |
7.86 |
8.39 |
| Liczba analityków (Przychody) |
15 |
22 |
14 |
6 |
9 |
| Liczba analityków (EPS) |
10 |
16 |
11 |
5 |
4 |
| symbol |
SRPT |
SRPT |
SRPT |
SRPT |
SRPT |